Kathy Hibbs
Direktor/Vorstandsmitglied bei SOPHIA GENETICS SA
Vermögen: 766 980 $ am 30.04.2024
Profil
Ms. Kathy L.
Hibbs is a Chief Administrative Officer at 23andMe, Inc. She is on the Board of Directors at Standard BioTools, Inc., SOPHiA GENETICS SA and Cadex Genomics Corp.
Ms. Hibbs was previously employed as an Independent Director by SomaLogic, Inc., an Independent Director by Veracyte SD, Inc., a Chief Administrative Officer by 23andMe Holding Co., a Secretary, Senior Vice President & General Counsel by Genomic Health, Inc., a Secretary, Senior Vice President & General Counsel by Monogram Biosciences, Inc., a Director-Legal Affairs by Varian Associates, Inc., a Vice President & General Counsel by Multitude, Inc., and a Counsel by Granite Bank, FSB (San Francisco, California).
She received her undergraduate degree from the University of California, Riverside and a graduate degree from the University of California, Hastings.
Bekannte Unternehmensbeteiligungen
Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
---|---|---|---|---|
20.05.2024 | 1 217 033 ( 0,39% ) | 558 618 $ | 30.04.2024 | |
SOPHIA GENETICS SA
0,06% | 15.02.2024 | 37 414 ( 0,06% ) | 185 199 $ | 30.04.2024 |
10.07.2023 | 50 462 ( 0,03% ) | 23 162 $ | 30.04.2024 | |
STANDARD BIOTOOLS INC.
-.--% | 10.04.2024 | 0 ( -.--% ) | - $ | 30.04.2024 |
Aktive Positionen von Kathy Hibbs
Unternehmen | Position | Beginn |
---|---|---|
SOPHIA GENETICS SA | Direktor/Vorstandsmitglied | 01.03.2021 |
STANDARD BIOTOOLS INC. | Direktor/Vorstandsmitglied | 05.01.2024 |
23andMe, Inc.
23andMe, Inc. Medical SpecialtiesHealth Technology 23andMe, Inc. provides genetic information using DNA analysis technologies and web-based interactive tools. It enables individuals to gain deeper insights into personal ancestry, genealogy, and inherited traits. The company was founded by Linda Avey, Paul L. Cusenza and Anne E. Wojcicki in 2006 and is headquartered in Sunnyvale, CA. | Verwaltungsdirektor | 01.01.2022 |
Cadex Genomics Corp.
Cadex Genomics Corp. BiotechnologyHealth Technology Cadex Genomics Corp. develops novel blood-based assays for patients with cancer. The company is based in Saint Louis, MO. The company was founded in 2018 by Sudhir Sinha, Bill Haack, Patrick Hall. Bill Haack has been the CEO since 2018. | Direktor/Vorstandsmitglied | 01.10.2019 |
Ehemalige bekannte Positionen von Kathy Hibbs
Unternehmen | Position | Ende |
---|---|---|
23ANDME HOLDING CO. | Verwaltungsdirektor | 24.05.2024 |
STANDARD BIOTOOLS INC. | Direktor/Vorstandsmitglied | 05.01.2024 |
GENOMIC HEALTH, INC. | General Counsel | 01.03.2014 |
Monogram Biosciences, Inc.
Monogram Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Monogram Biosciences, Inc. develops and commercializes diagnostic products for the treatment of human immunodeficiency virus (HIV) infection, hepatitis C virus (HCV) infection, and other viral illnesses, as well as cancer and other diseases. It offers HIV tests, including genotypic, phenotypic, tropism, and combined phenotype and genotype assays, suppression management and viral load testing, HCV assays and oncology tests. The company was founded in 1995 and is headquartered in South San Francisco, CA. | General Counsel | 01.10.2009 |
Multitude, Inc.
Multitude, Inc. Packaged SoftwareTechnology Services Multitude, Inc. provides software and analytic tools that help government and industry leaders transform data from the emergent. The company was founded by Nick Masson in 2015 and is headquartered in San Francisco, CA. | General Counsel | - |
Ausbildung von Kathy Hibbs
University of California, Riverside | Undergraduate Degree |
University of California, Hastings | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 4 |
---|---|
STANDARD BIOTOOLS INC. | Health Technology |
SOPHIA GENETICS SA | Technology Services |
23ANDME HOLDING CO. | Health Technology |
STANDARD BIOTOOLS INC. | Commercial Services |
Private Unternehmen | 8 |
---|---|
Varian Medical Systems, Inc.
Varian Medical Systems, Inc. Medical SpecialtiesHealth Technology Varian Medical Systems, Inc. engages in the manufacture of medical devices and software for treating cancer and other medical conditions. It operates through the Oncology Systems and Proton Solutions segments. The Oncology Systems segment designs, manufactures, sells, and services hardware and software products for treating cancer with conventional radiation therapy, and advanced treatments. The Proton Solutions segment delivers proton therapy, a form of external beam radiotherapy using proton beams for the treatment of cancer. The company was founded by William Hansen, Edward Ginzton, Russell Varian, and Sigurd Varian in 1948 and is headquartered in Palo Alto, CA. | Health Technology |
Monogram Biosciences, Inc.
Monogram Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Monogram Biosciences, Inc. develops and commercializes diagnostic products for the treatment of human immunodeficiency virus (HIV) infection, hepatitis C virus (HCV) infection, and other viral illnesses, as well as cancer and other diseases. It offers HIV tests, including genotypic, phenotypic, tropism, and combined phenotype and genotype assays, suppression management and viral load testing, HCV assays and oncology tests. The company was founded in 1995 and is headquartered in South San Francisco, CA. | Commercial Services |
Genomic Health, Inc.
Genomic Health, Inc. Medical SpecialtiesHealth Technology Genomic Health, Inc. engages in the provision of genomic-based diagnostic tests. Its tests analyze the underlying biology of cancers, allowing physicians and patients to make individualized treatment decisions. The firm uses a platform which translates a massive amount of clinical and genomic data into clinically actionable results for treatment planning. The company was founded by Patrick F. Terry, Joffre B. Baker, Randal W. Scott, and Steven Shak in August 2000 and is headquartered in Redwood City, CA. | Health Technology |
Granite Bank, FSB (San Francisco, California) | Finance |
23andMe, Inc.
23andMe, Inc. Medical SpecialtiesHealth Technology 23andMe, Inc. provides genetic information using DNA analysis technologies and web-based interactive tools. It enables individuals to gain deeper insights into personal ancestry, genealogy, and inherited traits. The company was founded by Linda Avey, Paul L. Cusenza and Anne E. Wojcicki in 2006 and is headquartered in Sunnyvale, CA. | Health Technology |
Multitude, Inc.
Multitude, Inc. Packaged SoftwareTechnology Services Multitude, Inc. provides software and analytic tools that help government and industry leaders transform data from the emergent. The company was founded by Nick Masson in 2015 and is headquartered in San Francisco, CA. | Technology Services |
Veracyte SD, Inc.
Veracyte SD, Inc. Miscellaneous Commercial ServicesCommercial Services Decipher Biosciences, Inc. is a commercial-stage precision oncology company which engages in patient care improvement. The Company?s differentiated approach measures the biological activity of a patient?s entire tumor genome, known as whole transcriptome analysis, and applies proprietary machine learning algorithms to improve therapy selection and accelerate adoption of new therapies into the standard of care. Its novel prostate cancer genomic testing products examine the underlying biology of a patient?s tumor, enabling physicians to select an optimal therapy. The firm?s whole transcriptome analysis of clinical patient samples from its commercial channel and its participation in practice-changing clinical trials has allowed it to build and expand its Decipher GRID database GRID. The company was founded by Elai Davicioni, Timothy J. Triche, Bruce A. Schmidt, and Jonathan D. Buckley and is headquartered in San Diego, CA. | Commercial Services |
Cadex Genomics Corp.
Cadex Genomics Corp. BiotechnologyHealth Technology Cadex Genomics Corp. develops novel blood-based assays for patients with cancer. The company is based in Saint Louis, MO. The company was founded in 2018 by Sudhir Sinha, Bill Haack, Patrick Hall. Bill Haack has been the CEO since 2018. | Health Technology |